Fluticasone propionate - Open Access .click

Results 61 to 70 of about 16,409 (241)

IMPACT OF THE TYPE OF A BASIC THERAPY ON THE QUALITY OF LIFE IN CHILDREN WITH CONTROLLED MODERATELY SEVERE BRONCHIAL ASTHMA

Педиатрическая фармакология, 2010
The article provides results of a study for the impact of low doses fluticasone propionate and sodium nedocromil on the quality of life in children with bronchial asthma. It evidences Statistically valid improvements in the quality of life are identified
S.V. Bychkovskaya, N.A. Il'enkova, S.Yu. Tereschenko +2 more
doaj +2 more sources

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: A randomized non-inferiority study [PDF]

, 2018
Background: Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62.5/25 μg has been shown to improve lung function and health status, and reduce exacerbations, versus budesonide/formoterol in patients with chronic obstructive ...
Birk, Ruby +5 more
core +2 more sources

Clinical Outcomes Associated With Long‐Acting Beta Agonist Escalation in Preschool Children With Severe Asthma: A Retrospective Hospital Based Clinic Cohort Study

Pediatric Pulmonology, Volume 61, Issue 5, May 2026.
ABSTRACT Background We define adherent, difficult‐to‐treat asthma as ‘true severe asthma.' In preschool children, evidence for add‐on long‐acting beta‐agonists (LABA) to inhaled corticosteroids (ICS) in those with persistent uncontrolled disease despite high‐dose ICS remains limited. We evaluated clinical outcomes of ICS–LABA therapy in this population.
Adi Meridor Eizner +3 more
wiley +1 more source

Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma

Journal of Asthma and Allergy, 2012
Richard H Stanford,1 Manan Shah,2 Anna O D'Souza21GlaxoSmithKline, Research Triangle Park, Durham, NC, 2Xcenda, Palm Harbor, FL, USABackground: The purpose of this study (GSK ADA111194) was to compare asthma-related health care utilization and ...
Stanford RH, Shah M, D'Souza AO
doaj

Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2018
Inhaled corticosteroids are widely used in the treatment of chronic obstructive pulmonary disease (COPD). However, their use has been questioned for appropriate dose and a possible increased risk of pneumonia. Here, we reviewed patients with COPD who had
Hideki Yasui +16 more
doaj +1 more source

Successful Treatment of Pigmented Purpuric Dermatoses With Abrocitinib: A Case Report

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Pigmented Purpuric Dermatoses (PPD) are chronic conditions often resistant to standard treatments, creating a need for new therapies, particularly for those suffering from severe itching. This report details a patient with a year of refractory lower‐extremity PPD who failed multiple oral and topical treatments.
Yuping Zhang, Xiji Lu, Chen Li
wiley +1 more source

Withdrawal from treatment as an outcome in the Isolde study of COPD [PDF]

, 2003
Objectives: To investigate the determinants of patient withdrawal from our study, and the effect of these withdrawals on the outcome of treatment with inhaled corticosteroids in patients with COPD.
American Thoracic Society +27 more
core +1 more source

Is There a Topical Nasal Steroid Spray That Works the Best for Nasal Congestion?

The Laryngoscope, EarlyView.
Benjamin Aunins +3 more
wiley +1 more source

Allergic Rhinitis and Its Impact on Asthma (ARIA)‐EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments

Allergy, Volume 81, Issue 4, Page 954-976, April 2026.
ABSTRACT Background Allergic rhinitis (AR) impacts quality of life, work and school productivity. Over the last years, an important body of evidence resulting from mHealth data has led to a better understanding of AR. Such advances have motivated an EAACI‐endorsed update of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines (ARIA 2024 ...
Bernardo Sousa‐Pinto +252 more
wiley +1 more source

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD

Frontiers in Pharmacology, 2018
Background: Prospective pharmacological studies on breathomics profiles in COPD patients have not been previously reported. We assessed the effects of treatment and withdrawal of an extrafine inhaled corticosteroid (ICS)-long-acting β2-agonist (LABA ...
Paolo Montuschi +14 more
doaj +1 more source

medicine
internal medicine
fluticasone

asthma
corticosteroid
anesthesia

pharmacology
salmeterol
copd